Appello Pharmaceuticals, Inc. — Form D
Appello Pharmaceuticals, Inc. of NASHVILLE, TN, a company, filed a Form D exempt-offering notice with the SEC on 2018-07-10. The offering totals $10.2M, of which $4.5M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2018-07-10
- Form: D
- Accession: 0001745654-18-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $10.2M
- Amount sold: $4.5M
- Remaining: $5.7M
- Minimum investment: $1
- Investors: 5
- Date of first sale: 2018-06-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-316410
Issuer
- Name: Appello Pharmaceuticals, Inc.
- CIK: 0001745654
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 3835 CLEGHORN AVE, NASHVILLE, TN, 37215
- Phone: (615) 515-9880
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Brian Laden | Director | Nashville, TN |
| Brian Laden | Executive Officer | Nashville, TN |
| Vaughn Bryson | Director | Nashville, TN |
| Howard P Furst | Director | Nashville, TN |
| Christopher P Rand | Executive Officer | Nashville, TN |
| Joseph P Cook, Jr. | Director | Nashville, TN |
| William P Slattery | Director | Nashville, TN |
| Jeff P Conn | Director | Nashville, TN |
| Howie P Furst | Director | New York, NY |
Other filings by this issuer (2)
More